12:00 AM
 | 
Dec 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

GlaxoSmithKline, Fred Hutchinson deal

GlaxoSmithKline and the research center partnered under GSK's Discovery Partnerships with Academia to develop products to treat facioscapulohumeral muscular dystrophy (FSHD). The center will receive an undisclosed upfront payment and research expenses and is eligible for undisclosed milestones and royalties. GSK...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >